A roundup of the most impactful FDA approvals in women’s health from January through June 2025, spanning diagnostics, therapeutics, and at-home care.
Morgan Ebert, Managing Editor
Advertisement
Morgan Ebert is managing editor of Contemporary OB/GYN® and Contemporary Pediatrics®. She joined the MJH Life Sciences team in December 2019. She graduated from Youngstown State University in 2019 with a bachelor's degree in journalism and a minor in political science. Prior to graduating, Morgan worked as the editor-in-chief of her college newspaper. She went on to work as an assignment editor at a broadcast news station in Youngstown, Ohio, before joining the Contemporary brands. You can reach her at mebert@mjhlifesciences.com.
Articles by Morgan Ebert, Managing Editor
A look back at the most important FDA approvals, clinical research, and expert perspectives shaping ob-gyn care in the first half of 2025.
Take a quick look at everything you may have missed during Q2 of 2025, including the latest FDA approvals, top stories, and exclusive interviews.
Take a quick look at everything you may have missed last month, including the latest FDA updates and top stories.
Oral sulopenem (ORLYNVAH; Iterum Therapeutics) was non-inferior to amoxicillin/clavulanate for treating uUTIs in women, per the phase 3 REASSURE trial.
Wildfire smoke and heat stress before and early in pregnancy raise the risk of SGA births, especially in climate-vulnerable neighborhoods.
Higher third-trimester glucose levels in insulin-dependent pregnancies are tied to increased obesity risk in adult offspring, a 40-year study finds.
In a recent study, prenatal PFAS exposure was linked to higher adolescent blood pressure, with stronger effects in boys and children born to non-Hispanic Black mothers.
The American Academy of Pediatrics urges clinicians to offer confidential, adolescent-centered contraceptive care using evidence-based, equity-informed approaches.
A recent study found that women with colorectal cancer face an increased long-term risk of pain during sex, early menopause, and pelvic disease.
Childhood adversity may raise endometriosis risk, with exposure to violence linked to a twofold increase, a Swedish study finds.
Daily trimethoprim–sulfamethoxazole in pregnancy reduced preterm births, especially in women with HIV, but did not significantly affect birth weight.
New 14-gene test allows early, precise assessment without partner samples.
Take a quick look at everything you may have missed last month, including the latest FDA updates, top stories, and exclusive interviews.
Find out what you may have missed at the 2025 ACOG ACSM.
Research presented at the 2025 ACOG ACSM highlighted the potential risks tied to personal care product use among African American pregnant patients.
In an abstract featured at the 2025 ACOG ACSM, researchers found that after Dobbs, North Carolina saw more out-of-state abortion patients, longer wait times, and increased racial disparities.
A comparison of 4 ultrasound-based algorithms demonstrated strong performance, with nuanced implications for clinical practice, according to a new study presented at the 2025 ACOG ACSM.
A recent study presented at the 2025 ACOG Annual Clinical and Scientific Meeting found that most TikTok videos on hormonal contraception was misleading.
A new study presented at 2025 ACOG Annual Clinical and Scientific Meeting found disparities between RSV uptake in pregnant patients.
Azithromycin and doxycycline carry a greater risk of vulvovaginal candidiasis compared to other acne treatments, researchers report at ACOG ACSM 2025.
A meta-analysis presented at 2025 ACOG Annual Clinical & Scientific Meeting found that elinzanetant demonstrated a reduction in VMS frequency and intensity.
Shared decision making and individualized strategies are emphasized in the new ACOG consensus.
A quick look into some of the top sessions occurring at the 2025 ACOG Annual Clinical and Scientific Meeting, being held from May 16-18, 2025, in Minneapolis, Minnesota.
Take a quick look at everything you may have missed last month, including the latest FDA updates, top stories, and exclusive interviews.
New guidelines on GSM recommends symptom-based diagnosis, shared decision-making, and local estrogen as first-line therapy to improve quality of life.
A UK study links maternal anemia in early pregnancy with increased congenital heart disease risk in offspring.
Find out the top 5 latest updates and headlines in fertility research in honor of National Infertility Awareness Week (April 20-26, 2025).
A new survey highlights gender differences in knowledge and attitudes toward GLP-1/GIP receptor agonists.
A novel oral antibiotic, gepotidacin (Blujepa; GSK), has demonstrated its effectiveness in treating uncomplicated urogenital gonorrhea, according to the results of a recent phase 3 clinical trial.
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Deborah Anderson, PhD, calls for expanded contraception access
2
High rates of misdiagnosis reported among perimenopausal women
3
Contemporary OB/GYN week in review: alcohol use, cardiac rehabilitation, and more
4
Sleep problems tied to higher hypertension odds in postmenopausal women
5
